Could a diabetes pill lift bipolar depression? new study hopes so.
NCT ID NCT07472920
First seen Mar 27, 2026 · Last updated May 24, 2026 · Updated 11 times
Summary
This study tests whether empagliflozin, a medicine used for diabetes, can help reduce depression in people with bipolar disorder who also have insulin resistance. Insulin resistance is common in bipolar disorder and may worsen mood symptoms. The study will involve 20 adults over 12 weeks, measuring changes in depression severity and insulin resistance.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INSULIN RESISTANCE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Institute of Psychiatry, University of São Paulo Medical School (IPq-FMUSP)
São Paulo, São Paulo, 05403-903, Brazil
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.